That aside, scientists now say that drugs like Ozempic could be used to treat diabetes and reduce dementia risk ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

The study supports prior research that found the same thing.

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

like Ozempic, like Mounjaro, may reduce the risk of dementia in people who are on those drugs," Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists, could significantly reduce the risk of developing any type of dementia, according to a meta-analysis of 26 ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, ...